| 标题 |
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Jean‐Charles Soria; Daniel S.W. Tan; Rita Chiari; Yi‐Long Wu; Luis Paz‐Ares; et al 出版日期:2017-01-24 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)